Advocacy intelligence hub — real-time data for patient organizations
Cabaletta Bio — PHASE1, PHASE2
Tr1X, Inc. — PHASE1, PHASE2
Heinrich-Heine University, Duesseldorf
University of California, Davis — PHASE1
University of Brawijaya — PHASE2
University Hospital, Bordeaux — NA
VA Office of Research and Development — PHASE1
Hoffmann-La Roche — PHASE3
Kessler Foundation — NA
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs